Menu Close

Donating Plasma From the Recovered to Help the Sick

In the fight against the COVID-19 pandemic, the U.S Food and Administrative department has been making efforts with the U.S government, academia and industries to accelerate the development and availability of critical medical products to the COVID patients with severe symptoms.

Presently, the FDA has approved a treatment that is called the convalescent plasma. Plasma is a yellowish liquid in blood. It carries antibodies. The body’s immune system makes those antibodies (special proteins) in response to a virus or vaccine. Those proteins can bind to a virus and help to remove the infection. People who have already recovered from COVID19 have antibodies that are capable to fight against the disease. Researchers have a hope towards the convalescent plasma can be given to patients with severe symptoms and help them fight against coronavirus. The main goal of this research is to determine if the convalescent plasma can help in the recovery of the people with the most severe disease. Secondly, it is to test whether the plasma can help people who are moderately sick from getting worse.

(https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-encourages-recovered-patients-donate-plasma-development-blood)

(https://www.mayoclinic.org/diseases-conditions/coronavirus/expert-answers/convalescent-plasma/faq-20484383 )

(https://www.sciencenewsforstudents.org/article/antibodies-covid-19-recovered-patients-treatment)

Microsoft company has developed a ‘Plasmabot’ that encourages recovered patients to donate their plasma to treat the sick. Vitalant, a non-profit organization that helps with providing and donating blood and other supplies have their first donor to be donating the plasma to treat the diseased person.

(https://www.cnbc.com/2020/04/18/microsoft-plasmabot-encourages-covid-19-survivors-to-donate-plasma.html )

(https://kfoxtv.com/news/local/plasma)

Numerous clinical trials have been taking place to evaluate the safety and efficacy of the convalescent plasma. The FDA had granted many single-patient emergency investigational new drug (eIND) applications as well. More than 1,040 sites and 950 physician investigators have signed to participate in the  Mayo Clinic-led expanded access protocol.  

The major key to ensure the availability of the plasma from the recovered COVID patients to help treat the infected people, is to donate the plasma. The FDA has launched a new webpage that will provide instructions on the eligibility, plasma collection centers, guidelines and schedule an appointment for the donation.  The American Red Cross has also come up with a webpage that will help in the donations((www.redcross.org/plasma4covid)

(https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/donate-covid-19-plasma)

(https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-encourages-recovered-patients-donate-plasma-development-blood)

Donating convalescent plasma and helping out severely ill patients to recover from the disease will be a goal to fight against the pandemic.

As the confirmed COVID cases and the death toll has increased, getting yourself tested is necessary. Locate testing centers near you with the help of https://www.carenearby.com/